Browse > Article

Enhancement of TRAIL-Induced Apoptosis in Human Hepatocellular Carcinoma Cells by Apigenin  

Kim, Eun-Young (College of Pharmacy, Sookmyung Women's University)
Kim, An-Keun (College of Pharmacy, Sookmyung Women's University)
Publication Information
YAKHAK HOEJI / v.55, no.1, 2011 , pp. 49-55 More about this Journal
Abstract
Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) is one of the promising anti-cancer agent because of its ability to selectively induce apoptosis in tumor cell lines but not in normal cells. However, TRAIL resistance has been reported in some cancer cells including hepatocarcinoma cells. Therefore, studies of agents that sensitize TRAIL-resistant cancer cells could be a effective therapeutic approach in cancer management. In our study, we examined the effect of combination of TRAIL with apigenin in human hepatocellular carcinoma cells. As a result, the combined use of TRAIL and apigenin significantly enhanced the cytotoxicity in PLC-PRF5 cells. Flow cytometry analysis after annexin V-FITC/PI dual staining showed that this increase of cell cytotoxicity was related to enhanced apoptosis in combined treatment of TRAIL with apigenin. Furthermore, synergistic induction of apoptosis was also confirmed by observation of morphological changes and annexin V-FITC/PI fluorescence. Our findings suggests that apigenin has the potential to improve the efficiency of TRAIL-based therapies in human hepatocellular carcinoma cells. Further study is needed to reveal the molecular mechanisms of this combined therapy.
Keywords
TRAIL; hepatocarcinoma cells; apigenin; combination; apoptosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Van Cruchten, S. and Van Den Broeck, W. : Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat. Histol. Embryol. 31, 214 (2002).   DOI   ScienceOn
2 Bossy-Wetzel, E. and Green, D. R. [2]Detection of apoptosis by annexin V labeling. Academic Press, City (2000).
3 Shounan, Y., Feng, X. and O'Connell, P. J. : Apoptosis detection by annexin V binding: a novel method for the quantitation of cell-mediated cytotoxicity. J. Immunol. Methods 217, 61 (1998).   DOI
4 Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M. S., Luthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., Shimamoto, G., DeRose, M., Elliott, R., Colombero, A., Tan, H. L., Trail, G., Sullivan, J., Davy, E., Bucay, N., Renshaw-Gegg, L., Hughes, T. M., Hill, D., Pattison, W., Campbell, P., Sander, S., Van, G., Tarpley, J., Derby, P., Lee, R. and Boyle, W. J. : Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309 (1997).   DOI   ScienceOn
5 Holoch, P. A. and Griffith, T. S. : TNF-related apoptosis-inducing ligand (TRAIL): A new path to anti-cancer therapies. Eur. J. Pharmacol. 625, 63 (2009).   DOI   ScienceOn
6 Oldenhuis, C., Stegehuis, J. H., Walenkamp, A. M. E., de Jong, S. and de Vries, E. G. E. : Targeting TRAIL death receptors. Curr. Opin. Pharmacol. 8, 433 (2008).   DOI   ScienceOn
7 Huang, Y. and Sheikh, M. S. : TRAIL death receptors and cancer therapeutics. Toxicol. Appl. Pharm. 224, 284 (2007).   DOI   ScienceOn
8 Morgan, D. M. : Tetrazolium (MTT) assay for cellular viability and activity. Method. Mol. Biol. 79, 179 (1998).
9 Griffith, T. S. and Lynch, D. H. : TRAIL: a molecule with multiple receptors and control mechanisms. Curr. Opin. Immunol. 10, 559 (1998).   DOI   ScienceOn
10 Burns, T. F. and El-Deiry, W. S. : Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach. J. Biol. Chem. 276, 37879 (2001).
11 Vermes, I., Haanen, C., Steffens-Nakken, H. and Reutellingsperger, C. : A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184, 39 (1995).   DOI   ScienceOn
12 Hacker, G. : The morphology of apoptosis. Cell Tissue Res. 301, 5 (2000).   DOI   ScienceOn
13 LeBlanc, H. N. and Ashkenazi, A. : Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ. 10, 66 (2003).   DOI   ScienceOn
14 World Health Organization, Fact sheet 297. Available at: http://www.who.int/mediacentre/factsheets/fs297/en/index.html.Accessed 2009.
15 Ministry for Heath, Welfare and Family Affairs. Annual report of cancer incidence (2005) and survival (1993-2005) in Korea. (2008).
16 Organization for Economic Co-operation and Development. Health at a Glance 2009: OECD indicators (2009).
17 Sheikh, M. S. and Huang, Y. : Death receptors as targets of cancer therapeutics. Curr. Cancer Drug Targets 4, 97 (2004).   DOI   ScienceOn